C

파라택시스코리아

288330KOSDAQ

54.5 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Parataxis Korea operates two main business segments: digital assets and biotechnology. In the digital asset division, the company holds Bitcoin as a strategic financial asset and aims to generate revenue through mining operations. The biotechnology division focuses on developing innovative drugs for unmet medical needs, with key candidates like BBT-207 and BBT-877 currently in clinical trials for lung cancer and idiopathic pulmonary fibrosis, respectively.

Number of Employees

16people

Average Salary

74.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
1.01Industry Average 1.204.0Point

In line with industry avg

ROE
-90.37Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
8.93Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲107.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲36.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -97.2% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 416Won52-week high 2,14552-week low 416
1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral주권매매거래정지 (투자자 보호)2026-08-20
  • Neutral기타시장안내 (정리매매 보류 관련)2026-08-20
  • Neutral기타경영사항(자율공시) (상장폐지 결정 효력정지 가처분신청)2026-08-20
  • Neutral기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내)2026-08-19
  • Neutral반기보고서 (2026.06)2026-08-14